-
In the wake of the 2014 midterm elections, Congress has shifted decidedly to the political right. When the 114th Congress convenes in January 2015, Republicans will have their largest majority in the House of Representatives since World War II and will control the Senate for the first time since 2007.
-
“Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention.
-
Nearly 50% of bariatric surgery patients are reproductive-age women. Obstetric and gynecology as well as surgery professional guidelines recommend a delay of pregnancy one to two years post-surgery.
-
A new national report indicates many at-risk teens are missing needed reproductive health services.
-
According to results of a national survey, physicians recommend human papillomavirus (HPV) vaccination to less than 15% of their male patients ages 9-26. Pediatric specialists and doctors who support new vaccines were more likely to recommend the vaccine, data indicate.
-
The Duke Clinical Research Institute is working with nine centers across the United States in a five-year project to evaluate the effectiveness of different treatment strategies for women with uterine fibroids.
-
Near the end of September 2014, the American Academy of Pediatrics (AAP) published its policy statement on contraception for adolescents.
-
Teens who received free contraception and were educated about the benefits and disadvantages of various birth control methods in the Contraceptive CHOICE Project in St. Louis were dramatically less likely to get pregnant, give birth, or obtain an abortion compared with other sexually active teens, data suggests in a just-released study.
-
Eleven research teams have received funding from the Bill and Melinda Gates Foundation of Seattle to pursue new condom designs that could help increase condom use by improving sexual sensation and other aspects of user experience.
-
The Centers for Disease Control and Prevention (CDC) has issued clinical guidance for use of anti-HIV drugs in uninfected patients who are at substantial risk of infection.
